Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications
- PMID: 9673834
- DOI: 10.2165/00003088-199835010-00004
Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications
Abstract
Age-related changes in pharmacokinetics principally affect drug absorption, distribution, metabolism and elimination. Changes in pharmacodynamics are primarily seen in the cardiovascular and neuroendocrine system. Age-dependent changes in the kinetics and dynamics of drugs acting on the cardiovascular system and central nervous system are common, and this review, while by no means exhaustive of the effects of drugs on all organ systems, is reflective of the principles and gives examples of the effects of age on these 2 major systems. While pharmacokinetic changes in the elderly are usually well characterised, pharmacodynamic changes are understood only in the most preliminary way. There has been relatively little research in this area of geriatric clinical pharmacology, and pharmacodynamic changes are still an area of investigation.
Similar articles
-
Pharmacodynamics in older adults: a review.Am J Geriatr Pharmacother. 2007 Sep;5(3):263-303. doi: 10.1016/j.amjopharm.2007.10.001. Am J Geriatr Pharmacother. 2007. PMID: 17996666 Review.
-
Pharmacokinetic-pharmacodynamic crisis in the elderly.Am J Ther. 2007 Sep-Oct;14(5):488-98. doi: 10.1097/01.mjt.0000183719.84390.4d. Am J Ther. 2007. PMID: 17890940 Review.
-
Cardiovascular drug therapy in the elderly.Cardiol Rev. 2007 Jul-Aug;15(4):195-215. doi: 10.1097/CRD.0b013e3180301b69. Cardiol Rev. 2007. PMID: 17575484 Review.
-
Pharmacokinetic and pharmacodynamic principles of drug therapy in old age. Part 1.Int J Clin Pharmacol Ther Toxicol. 1989 Jan;27(1):13-26. Int J Clin Pharmacol Ther Toxicol. 1989. PMID: 2663734 Review.
-
Age-related changes in pharmacodynamics: focus on drugs acting on central nervous and cardiovascular systems.Curr Drug Metab. 2011 Sep;12(7):611-20. doi: 10.2174/138920011796504473. Curr Drug Metab. 2011. PMID: 21495972 Review.
Cited by
-
Clinically important drug interactions with intravenous anaesthetics in older patients.Drugs Aging. 2003;20(13):969-80. doi: 10.2165/00002512-200320130-00002. Drugs Aging. 2003. PMID: 14561101 Review.
-
Effect of age on the pharmacokinetics of duloxetine in women.Br J Clin Pharmacol. 2004 Jan;57(1):54-61. doi: 10.1046/j.1365-2125.2003.01963.x. Br J Clin Pharmacol. 2004. PMID: 14678340 Free PMC article. Clinical Trial.
-
Free drug metabolic clearance in elderly people.Clin Pharmacokinet. 2008;47(5):297-321. doi: 10.2165/00003088-200847050-00002. Clin Pharmacokinet. 2008. PMID: 18399712 Review.
-
Clinical pearls for the management of duloxetine patients with medical comorbidities.Ment Health Clin. 2024 Dec 2;14(6):313-320. doi: 10.9740/mhc.2024.12.313. eCollection 2024 Dec. Ment Health Clin. 2024. PMID: 39703684 Free PMC article.
-
Influence of age on the pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitor.Clin Pharmacokinet. 2003;42(4):381-92. doi: 10.2165/00003088-200342040-00006. Clin Pharmacokinet. 2003. PMID: 12648028 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources